NEWSROOM
![ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-4-1080x675.png)
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
Successful Conversion Eliminates Over $4 Million in Long-Term Debt New York, NY, August 26, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases, announces the successful conversion of its convertible promissory notes by investors. This strategic move significantly strengthens ANEW’s balance sheet by eliminating over $4 million in long-term debt. The elimination of over $4 million in...
![Biofuels Brazil Forum 2024](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-Ingles-1.png)
Biofuels Brazil Forum 2024
Biofuels Brazil Forum 2024 Date: 27-28 November 2024, Sao Paulo, BrazilOrganizer: Vostock CapitalWebsite "Biofuels Brazil International Investment Forum" is the premier platform for biofuel producers, regulatory bodies, government officials, technology pioneers, equipment suppliers, EPC, engineering companies, and investors from Brazil, Latin America, and Europe. It fosters strategic partnerships and innovation in the biofuels sector, advancing Brazil's leadership in sustainable development...
![Foro Biocombustibles Brasil 2024](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-Esanol.png)
Foro Biocombustibles Brasil 2024
Foro Biocombustibles Brasil 2024 Fecha: 27-28 de noviembre de 2024, São Paulo, BrasilOrganizador: Vostock CapitalWebsite El "Foro Internacional de Inversiones en Biocombustibles de Brasil" es la plataforma principal para productores de biocombustibles, organismos reguladores, funcionarios gubernamentales, pioneros tecnológicos, proveedores de equipos, empresas de EPC y de ingeniería, e inversores de Brasil, América Latina y Europa. Fomenta alianzas estratégicas e innovación en el sector de los...
![Fórum de Biocombustíveis Brasil 2024](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-Portugese.png)
Fórum de Biocombustíveis Brasil 2024
Fórum de Biocombustíveis Brasil 2024 Data: 27-28 de novembro de 2024, São Paulo, Brasil Organizador: Vostock Capital Website O "Fórum Internacional de Investimentos em Biocombustíveis Brasil" é a principal plataforma para produtores de biocombustíveis, órgãos reguladores, autoridades governamentais, pioneiros em tecnologia, fornecedores de equipamentos, empresas de EPC e engenharia, e investidores do Brasil, América Latina e de outras regiões. O evento promove parcerias...
![“Mining Chile and Latin America 2024” in Santiago de Chile](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-Ingles.png)
“Mining Chile and Latin America 2024” in Santiago de Chile
“Mining Chile and Latin America 2024” in Santiago de Chile Meet industry leaders and learn the best practices for the mining sector. Date: October 1st and 2nd 2024 Place: Santiago de Chile Organizer: Vostock Capital Website 5th International Congress and Exhibition Mining Chile and Latin America 2024 brings together, during two days, + 200 decision-makers from national and international companies, + 40 Mining Projects in Chile technology and service providers, and international...
![Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-11.png)
Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″
Congreso Internacional y Exhibición “Minería Chile y América Latina 2024" Fecha: 1 y 2 de octubre 2024 Lugar: Santiago de Chile Organizador: Vostock Capital Sitio Web El 5º Congreso y Exhibición Internacional Minería Chile y América Latina 2024 reúne a más de 200 ejecutivos con poder de decisión de empresas nacionales e internacionales, más de 40 proyectos de Mineria en America latina, proveedores de tecnología y servicios, inversionistas internacionales y locales para discutir las principales...
![Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research](https://prismmediawire.com/wp-content/uploads/2024/08/LIPO-Newsroom-1.png)
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research
Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouth No FDA-approved therapy currently exists for OLP Patient registry and OLP study information is now available Pittsburgh, PA, August 22, 2024 – Lipella Pharmaceuticals, Inc. (NASDAQ: LIPO) has launched an Oral Lichen Planus (OLP) Patient Registry. This online platform is designed to enhance research and drive the development of new treatments for OLP, a chronic inflammatory...
![BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-May-2024-2.png)
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
Study supports BioStem’s strategic growth initiatives and accelerates product adoption by providing data to healthcare professionals and payers on the benefits of Vendaje POMPANO BEACH, FL, August 21, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the Institutional Review Board (IRB) has approved a clinical study to evaluate Vendaje® for...
![ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility](https://prismmediawire.com/wp-content/uploads/2024/08/Newsroom-4-1080x675.png)
ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
New York, NY. August 21, 2024 - ANEW MEDICAL, INC. (“ANEW” or the “Company”) (NASDAQ: WENA), announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke(“TTS”)regarding Nanoject, a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines. Needle phobia and injection or blood-drawing anxiety are prevalent among adults and children, creating barriers to adhering to doctor visits and medication protocols. Alternatives to needle/syringes have...
![Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research](https://prismmediawire.com/wp-content/uploads/2024/08/LIPO-Newsroom-1.png)
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancer Novel MRI contrast agent, which received support from National Institute of Diabetes and Digestive and Kidney Diseases 5th International Consultation on Interstitial Cystitis Japan runs Aug. 21-23 in Kyoto Pittsburgh, PA, August 21, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotech company, will highlight clinical data on LP-20, a novel MRI contrast agent designed for diagnosing...